Multimodal apparent diffusion MRI model in noninvasive evaluation of breast cancer and Ki-67 expression.

IF 3.5 2区 医学 Q2 ONCOLOGY Cancer Imaging Pub Date : 2024-10-11 DOI:10.1186/s40644-024-00780-x
Huan Chang, Jinming Chen, Dawei Wang, Hongxia Li, Lei Ming, Yuting Li, Dan Yu, Yu Xin Yang, Peng Kong, Wenjing Jia, Qingqing Yan, Xinhui Liu, Qingshi Zeng
{"title":"Multimodal apparent diffusion MRI model in noninvasive evaluation of breast cancer and Ki-67 expression.","authors":"Huan Chang, Jinming Chen, Dawei Wang, Hongxia Li, Lei Ming, Yuting Li, Dan Yu, Yu Xin Yang, Peng Kong, Wenjing Jia, Qingqing Yan, Xinhui Liu, Qingshi Zeng","doi":"10.1186/s40644-024-00780-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To assess the capability of multimodal apparent diffusion (MAD) weighted magnetic resonance imaging (MRI) to distinguish between malignant and benign breast lesions, and to predict Ki-67 expression level in breast cancer.</p><p><strong>Methods: </strong>This retrospective study was conducted with 93 patients who had postoperative pathology-confirmed breast cancer or benign breast lesions. MAD images were acquired using a 3.0 T MRI scanner with 16 b values. The MAD parameters, as flow (f<sub>F</sub>, D<sub>F</sub>), unimpeded (fluid) (f<sub>UI</sub>), hindered (f<sub>H</sub>, D<sub>H</sub>, and α<sub>H</sub>), and restricted (f<sub>R</sub>, D<sub>R</sub>), were calculated. The differences of the parameters were compared by Mann-Whitney U test between the benign/malignant lesions and high/low Ki-67 expression level. The diagnostic performance was assessed by the area under the receiver operating characteristic curve (AUC).</p><p><strong>Results: </strong>The f<sub>R</sub> in the malignant lesions was significantly higher than in the benign lesions (P = 0.001), whereas the f<sub>UI</sub> and D<sub>H</sub> were found to be significantly lower (P = 0.007 and P < 0.001, respectively). Compared with individual parameter in differentiating malignant from benign breast lesions, the combination parameters of MAD (f<sub>R</sub>, D<sub>H</sub>, and f<sub>UI</sub>) provided the highest AUC (0.851). Of the 73 malignant lesions, 42 (57.5%) were assessed as Ki-67 low expression and 31 (42.5%) were Ki-67 high expression. The Ki-67 high status showed lower D<sub>H</sub>, higher D<sub>F</sub> and higher α<sub>H</sub> (P < 0.05). The combination parameters of D<sub>H</sub>, D<sub>F</sub>, and α<sub>H</sub> provided the highest AUC (0.691) for evaluating Ki-67 expression level.</p><p><strong>Conclusions: </strong>MAD weighted MRI is a useful method for the breast lesions diagnostics and the preoperative prediction of Ki-67 expression level.</p>","PeriodicalId":9548,"journal":{"name":"Cancer Imaging","volume":"24 1","pages":"137"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11470582/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40644-024-00780-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To assess the capability of multimodal apparent diffusion (MAD) weighted magnetic resonance imaging (MRI) to distinguish between malignant and benign breast lesions, and to predict Ki-67 expression level in breast cancer.

Methods: This retrospective study was conducted with 93 patients who had postoperative pathology-confirmed breast cancer or benign breast lesions. MAD images were acquired using a 3.0 T MRI scanner with 16 b values. The MAD parameters, as flow (fF, DF), unimpeded (fluid) (fUI), hindered (fH, DH, and αH), and restricted (fR, DR), were calculated. The differences of the parameters were compared by Mann-Whitney U test between the benign/malignant lesions and high/low Ki-67 expression level. The diagnostic performance was assessed by the area under the receiver operating characteristic curve (AUC).

Results: The fR in the malignant lesions was significantly higher than in the benign lesions (P = 0.001), whereas the fUI and DH were found to be significantly lower (P = 0.007 and P < 0.001, respectively). Compared with individual parameter in differentiating malignant from benign breast lesions, the combination parameters of MAD (fR, DH, and fUI) provided the highest AUC (0.851). Of the 73 malignant lesions, 42 (57.5%) were assessed as Ki-67 low expression and 31 (42.5%) were Ki-67 high expression. The Ki-67 high status showed lower DH, higher DF and higher αH (P < 0.05). The combination parameters of DH, DF, and αH provided the highest AUC (0.691) for evaluating Ki-67 expression level.

Conclusions: MAD weighted MRI is a useful method for the breast lesions diagnostics and the preoperative prediction of Ki-67 expression level.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无创评估乳腺癌和 Ki-67 表达的多模态表观弥散 MRI 模型
研究背景目的:评估多模态表观弥散(MAD)加权磁共振成像(MRI)区分乳腺恶性和良性病变以及预测乳腺癌Ki-67表达水平的能力:这项回顾性研究的对象是93名术后病理证实为乳腺癌或良性乳腺病变的患者。使用 3.0 T MRI 扫描仪采集了 16 个 b 值的 MAD 图像。计算了 MAD 参数,包括流动(fF、DF)、无阻(流体)(fUI)、受阻(fH、DH 和 αH)和受限(fR、DR)。通过 Mann-Whitney U 检验比较良性/恶性病变和高/低 Ki-67 表达水平之间的参数差异。诊断性能通过接收者操作特征曲线下面积(AUC)进行评估:恶性病变的 fR 明显高于良性病变(P = 0.001),而 fUI 和 DH 则明显低于良性病变(P = 0.007,P R、DH 和 fUI 的 AUC 最高(0.851)。在 73 个恶性病灶中,42 个(57.5%)被评估为 Ki-67 低表达,31 个(42.5%)为 Ki-67 高表达。Ki-67高表达状态显示较低的DH、较高的DF和较高的αH(P H、DF和αH为评估Ki-67表达水平提供了最高的AUC(0.691)):结论:MAD 加权磁共振成像是诊断乳腺病变和术前预测 Ki-67 表达水平的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Imaging
Cancer Imaging ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
7.00
自引率
0.00%
发文量
66
审稿时长
>12 weeks
期刊介绍: Cancer Imaging is an open access, peer-reviewed journal publishing original articles, reviews and editorials written by expert international radiologists working in oncology. The journal encompasses CT, MR, PET, ultrasound, radionuclide and multimodal imaging in all kinds of malignant tumours, plus new developments, techniques and innovations. Topics of interest include: Breast Imaging Chest Complications of treatment Ear, Nose & Throat Gastrointestinal Hepatobiliary & Pancreatic Imaging biomarkers Interventional Lymphoma Measurement of tumour response Molecular functional imaging Musculoskeletal Neuro oncology Nuclear Medicine Paediatric.
期刊最新文献
Correction: Optimization and validation of echo times of point-resolved spectroscopy for cystathionine detection in gliomas. Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer. Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures. Seeing through "brain fog": neuroimaging assessment and imaging biomarkers for cancer-related cognitive impairments. Prediction of lateral lymph node metastasis with short diameter less than 8 mm in papillary thyroid carcinoma based on radiomics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1